Prot# CY 4031:A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability and Efficacy of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/163/1/19

Funding

  • Parexel (Prot#CY 4031)
  • Cytokinetics, Inc. (Prot#CY 4031)